-
ALSO READ
Lupin signs agreement with Sunovion Pharmaceuticals Inc.
Granules India arm receives USFDA approval for ADHD drug
Granules receives USFDA approval for Amphetamine Mixed Salts ER capsules
Lupin gains on launching inhalation solution in US
Lupin to acquire two inhalation brands from Sunovion
-
Lurasidone Hydrochloride Tablets, 20 mg, 40 mg, 60 mg, 80 mg and 120 mg (RLD Latuda) had estimated annual sales of USD 4.2 billion in the U.
S. (IQVIA MAT December 2022).
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
Subscribe to Business Standard Premium
Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!
Insightful news, sharp views, newsletters, e-paper, and more! Unlock incisive commentary only on Business Standard.
Download the Business Standard App for latest Business News and Market News .
RECOMMENDED FOR YOU